Register entry

Arevipharma GmbH

Registered sites
1
Drug products
12
Live patents
0
Countries
1
Base
Germany
Authorisation

Registered operations

What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.

Active ingredient (API) manufacture
Sites

Facilities

1
SiteLocationOperationsFEI
Arevipharma GmbHRadebeulGermanyActive ingredient (API) manufacture1000505976
Catalogue

Marketed products

12

Showing 12 of 12.

BrandGeneric nameFormCategory
-Arketamine HydrochloridePOWDERBULK INGREDIENT
-Bisoprolol fumaratePOWDERBULK INGREDIENT
-BuprenorphinePOWDERBULK INGREDIENT
-Buprenorphine hydrochloridePOWDERBULK INGREDIENT
-Diethylpropion HydrochloridePOWDERBULK INGREDIENT
-Dimethyl FumaratePOWDERBULK INGREDIENT
-Doxapram hydrochloride monohydratePOWDERBULK INGREDIENT
-Esketamine HydrochloridePOWDERBULK INGREDIENT
-ImepitoinPOWDERBULK INGREDIENT
-Ketamine HydrochloridePOWDERBULK INGREDIENT
-NaltrexonePOWDERBULK INGREDIENT
-Remifentanil HydrochloridePOWDERBULK INGREDIENT
Provenance

Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.